Literature DB >> 19389790

Effect of revascularizing viable myocardium on left ventricular diastolic function in patients with ischaemic cardiomyopathy.

Erberto Carluccio1, Paolo Biagioli, Gianfranco Alunni, Adriano Murrone, Valeria Leonelli, Paola Pantano, Gabriella Vincenti, Claudio Giombolini, Temistocle Ragni, Gianpaolo Reboldi, Federico Gentile, Giuseppe Ambrosio.   

Abstract

AIMS: In patients with ischaemic left ventricular (LV) dysfunction and viable myocardium, revascularization improves systolic function. Diastolic dysfunction is also present in such patients; however, whether revascularization improves diastolic function also is largely unknown.
METHODS: Twenty-six patients with chronic ischaemic cardiomyopathy [ejection fraction (EF) 32 +/- 6%, wall motion score index (WMSI) 2.45 +/- 0.33] and viable myocardium (low-dose dobutamine echocardiography) were examined at baseline and > or =4 months after revascularization. Diastolic function was assessed by transmitral pulsed-wave Doppler and tissue Doppler imaging (TDI) at the mitral annulus.
RESULTS: At baseline, 62% of patients showed non-restrictive filling (non-RF) pattern, and 38% restrictive filling (RF) pattern. After revascularization, along with improvement in systolic function (EF 43 +/- 10%, WMSI 1.78 +/- 0.47, P = 0.0002 for both), diastolic filling improved in most patients, with only three patients still exhibiting RF pattern (P = 0.016); furthermore, E' velocity increased (32 +/- 42%, P = 0.0028) and E/E' decreased (-19 +/- 31%, P = 0.0378) compared with baseline. Left ventricular filling pressure also decreased, from 17.5 +/- 6.8 to 13.1 +/- 6.5 mmHg (P = 0.005). Improvement of diastolic function by TDI was related to the extent of viability at baseline (P = 0.0098) and to LV reverse remodelling after revascularization (P = 0.0092).
CONCLUSION: In patients with ischaemic cardiomyopathy, LV diastolic filling may largely improve after revascularization. Improvement of diastolic dysfunction is related to the amount of viable tissue and it may represent an additional advantage of revascularizing dyssinergic but viable myocardium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389790     DOI: 10.1093/eurheartj/ehp125

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

1.  The role of cardiac magnetic resonance imaging following acute myocardial infarction.

Authors:  Dennis T L Wong; James D Richardson; Rishi Puri; Adam J Nelson; Angela G Bertaso; Karen S L Teo; Matthew I Worthley; Stephen G Worthley
Journal:  Eur Radiol       Date:  2012-03-25       Impact factor: 5.315

2.  Reduced left atrial early strain rate following acute sleep deprivation: chance finding or chance to find out more on the conundrum of sleep and cardiovascular disease?

Authors:  Micha T Maeder
Journal:  Sleep Breath       Date:  2012-11-13       Impact factor: 2.816

Review 3.  Imaging: guiding the clinical translation of cardiac stem cell therapy.

Authors:  Patricia K Nguyen; Feng Lan; Yongming Wang; Joseph C Wu
Journal:  Circ Res       Date:  2011-09-30       Impact factor: 17.367

4.  Effect of Percutaneous Coronary Intervention on Diastolic Function in Coronary Artery Disease.

Authors:  Puneet Aggarwal; Santosh Kumar Sinha; Rishabh Marwah; Ranjit Kumar Nath; Bhagya Narayan Pandit; Ajay Pratap Singh
Journal:  J Cardiovasc Echogr       Date:  2021-07-28

5.  Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy.

Authors:  Qi Wang; Kang-Yu Chen; Fei Yu; Hao Su; Chun-Sheng An; Yang Hu; Dong-Mei Yang; Jian Xu; Ji Yan
Journal:  Clinics (Sao Paulo)       Date:  2017-07       Impact factor: 2.365

6.  Myocardial viability testing: all STICHed up, or about to be REVIVED?

Authors:  Matthew Ryan; Holly Morgan; Amedeo Chiribiri; Eike Nagel; John Cleland; Divaka Perera
Journal:  Eur Heart J       Date:  2022-01-13       Impact factor: 29.983

7.  Prognostic value of left ventricular diastolic dysfunction in patients undergoing cardiac catheterization for coronary artery disease.

Authors:  Hidekatsu Fukuta; Nobuyuki Ohte; Kazuaki Wakami; Toshihiko Goto; Tomomitsu Tani; Genjiro Kimura
Journal:  Cardiol Res Pract       Date:  2012-04-12       Impact factor: 1.866

8.  Evolution of Diastolic Dysfunction in Patients with Coronary Slow Flow Phenomenon and Acute Non-ST Segment Elevation Myocardial Infarction.

Authors:  Ahmed El Zayat; Mahmoud Abdelaziz; Ahmed Yousry; Ismail Ibrahim
Journal:  J Cardiovasc Imaging       Date:  2021-04-06

9.  The Evolution of Diastolic Function may be a Marker of Myocardial Ischemia in Coronary Slow Flow Phenomenon.

Authors:  Hyun-Jung Lee
Journal:  J Cardiovasc Imaging       Date:  2021-04-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.